Serious Adverse Events are an important FDA requirement for over-the-counter (OTC) drugs and dietary supplement in the United States. Learn the background and history of SAE reporting regulations, the challenges of deciding what constitutes a SAE, when and how to report an Adverse Event as well as the differences between reporting requirements for OTC drugs and dietary supplements vs. requirements for cosmetics. 

 

Presented by CHPA/EAS Consulting Group, LLC

Moderated by Marcia D. Howard, Ph.D., Senior Director, Regulatory & Scientific Affairs, CHPA

Webinar Objectives
  • Learn FDA definition of a serious adverse event and how it relates to a company's reporting obligations.
  • The role of the Healthcare professional in SAE reporting.
  • Is reporting a SAE admission that your product caused the event?
  • The Personal Care Products Safety Act and how this will change SAE reporting for Cosmetics.
  • Understand specific SAE reporting and recordkeeping requirements and information.
Seminar Information
Date Presented:
February 20, 2018 2:00 PM Eastern
Length:
1 hour
CHPA Member Price:
$99.00
Non-Member Price:
$249.00
Adverse Event Reporting - What You Need to Know
Speaker Information
Norma Skolnik  [ view bio ]
Individual topic purchase: Selected
Subscription
You must be logged in to access CHPA Subscriptions.
To continue, you need to log in to CHPA. If you have any questions about your account please contact us at 1-866-702-3278.
Email Address:
Password: